Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used to diagnose human diseases and screen donated human blood. Gen-Probe markets a broad portfolio of products that use the Company's patented technologies to detect infectious microorganisms, including those causing sexually transmitted diseases (STDs), tuberculosis, strep throat, pneumonia ... More >>
Gen-Probe Reports Financial Results for the Second Quarter of 2010 - 07/29/10
Total Revenues Increase 15%, to $138.6 Million, Driven by Blood Screening, Women's Health and Prodesse Products
Company Posts Non-GAAP EPS(1) of $0.52(2), 16% Higher than in the Prior Year Period, and GAAP EPS of $0.57
Strong Cash Generatio... Full Article >>
FDA Clears Prodesse's ProFAST(TM)+ Assay to Identify Three Strains of Influenza A, Including 2009 H1N1 - 07/26/10
SAN DIEGO, July 26, 2010 /PRNewswire via COMTEX/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the U.S. Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProFAST(TM)+ assay, making it the only FDA-cleared molecul... Full Article >>
Gen-Probe Announces Webcast of Second Quarter 2010 Earnings Conference Call - 07/13/10
SAN DIEGO, Jul 13, 2010 (BUSINESS WIRE) -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will release its second quarter 2010 financial results on Thursday, July 29, 2010 at approximately 4:00 p.m. Eastern Time (ET). The annou... Full Article >>
Gen-Probe Receives European CE Mark for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis - 06/30/10
SAN DIEGO, 30 June 2010 -- Gen-Probe Incorporated (NASDAQ: GPRO) announced today that it has received a European CE mark for its APTIMA® assay for Trichomonas vaginalis, a common parasitic sexually transmitted disease.
Gen-Probe’s APTIMA Trichomona... Full Article >>
Gen-Probe to Webcast Presentation at the Fifth Annual Piper Jaffray Europe Conference - 06/18/10
SAN DIEGO, June 18, 2010 /PRNewswire via COMTEX/ --Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the Fifth Annual Piper Jaffray Europe Conference in London on June 22 at approximately 11 a.m. British Summer Ti... Full Article >>
Gen-Probe Makes $50 Million Strategic Investment in Third Generation Sequencing Company Pacific Biosciences - 06/17/10
Companies to Collaborate on Developing Products for Clinical Diagnostics Use --
SAN DIEGO and MENLO PARK, Calif., June 17, 2010 /PRNewswire via COMTEX/ --Gen-Probe Incorporated (Nasdaq: GPRO) and Pacific Biosciences announced today that Gen-Pro... Full Article >>
Gen-Probe to Webcast Two Upcoming Investor Presentations - 06/10/10
-- William Blair 2010 Growth Stock Conference June 15 --
-- ThinkEquity's Mid-Year Check-Up on Healthcare June 16 --
SAN DIEGO, June 10, 2010 /PRNewswire via COMTEX/ --Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company wil... Full Article >>
Gen-Probe to Webcast Three Upcoming Investor Presentations - 06/03/10
- Jefferies 2010 Global Life Sciences Conference June 8 -
- 9th Annual Needham Healthcare Conference June 9 -
- GARP Research and Securities Investor Conference June 10 -
SAN DIEGO, June 3, 2010 /PRNewswire via COMTEX/ --Gen-Probe Incorporated (... Full Article >>
Gen-Probe Reports Financial Results for the First Quarter of 2010 - 04/29/10
Solid Growth in Women's Health, Acquisitions of Tepnel and Prodesse Drive 16% Increase in Product Sales, Total Revenues of $135.4 Million
Company Posts Non-GAAP and GAAP EPS(1)of $0.48(2)
Strong Cash Generation Continues, with $32.9 Million o... Full Article >>
Gen-Probe to Webcast Two Upcoming Investor Presentations - 04/27/10
Deutsche Bank 35th Annual Health Care Conference May 4
Bank of America Merrill Lynch Health Care Conference May 11
SAN DIEGO, April 27, 2010 /PRNewswire via COMTEX/ --Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will pr... Full Article >>
